Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. (Q35192183)

7 August 2017

1 reference

title

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. (English)

1 reference

7 August 2017

0 references

Jan Holmgren

1 reference

7 August 2017

Cecil Czerkinsky

1 reference

7 August 2017

Ali M Harandi

1 reference

7 August 2017

publication date

1 April 2003

1 reference

Expert Review of Vaccines

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

205-217

1 reference

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

The Toll receptor family and microbial recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

Toll-like receptors in the induction of the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

Imiquimod and resiquimod as novel immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.205

21 January 2018

Identifiers

DOI

10.1586/14760584.2.2.205

1 reference

7 August 2017

1 reference